Meza, J.; Glass, E.; Sandhu, A.K.; Li, Y.; Karanika, S.; Fessler, K.; Hui, Y.; Schill, C.; Wang, T.; Zhang, J.;
et al. Novel Vaccines Targeting the Highly Conserved SARS-CoV-2 ORF3a Ectodomain Elicit Immunogenicity in Mouse Models. Vaccines 2025, 13, 220.
https://doi.org/10.3390/vaccines13030220
AMA Style
Meza J, Glass E, Sandhu AK, Li Y, Karanika S, Fessler K, Hui Y, Schill C, Wang T, Zhang J,
et al. Novel Vaccines Targeting the Highly Conserved SARS-CoV-2 ORF3a Ectodomain Elicit Immunogenicity in Mouse Models. Vaccines. 2025; 13(3):220.
https://doi.org/10.3390/vaccines13030220
Chicago/Turabian Style
Meza, Jacob, Elizabeth Glass, Avinaash K. Sandhu, Yangchen Li, Styliani Karanika, Kaitlyn Fessler, Yinan Hui, Courtney Schill, Tianyin Wang, Jiaqi Zhang,
and et al. 2025. "Novel Vaccines Targeting the Highly Conserved SARS-CoV-2 ORF3a Ectodomain Elicit Immunogenicity in Mouse Models" Vaccines 13, no. 3: 220.
https://doi.org/10.3390/vaccines13030220
APA Style
Meza, J., Glass, E., Sandhu, A. K., Li, Y., Karanika, S., Fessler, K., Hui, Y., Schill, C., Wang, T., Zhang, J., Bates, R. E., Taylor, A. D., Kapoor, A. R., Ayeh, S. K., Karakousis, P. C., Markham, R. B., & Gordy, J. T.
(2025). Novel Vaccines Targeting the Highly Conserved SARS-CoV-2 ORF3a Ectodomain Elicit Immunogenicity in Mouse Models. Vaccines, 13(3), 220.
https://doi.org/10.3390/vaccines13030220
_Kwok.png)
